Form 4 for EW Edwards Lifesciences
Accepted 2023-02-06 00:00:00 ET · period of report 2023-02-06 · accession 0001225208-23-001375 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-06 | 2023-02-06 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $35.20 | +6,725 | 69.3K | +11% | +$236.7K |
| D | 2023-02-06 | 2023-02-06 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $80.75 | -6,725 | 62.6K | -10% | -$543.0K |
| D | 2023-02-06 | 2023-02-06 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $0.00 | -6,725 | 13.4K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-06 | M | A | 6,725 | $35.20 | 69,285.78 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-06 | S | D | 6,725 | $80.75 | 62,560.78 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Acquire) | 2023-02-06 | M | D | 6,725 | $0.00 | 13,450 | D | $35.20 · 2017-05-12 to 2023-05-11 | 6,725 Common Stock |